Previous 10 | Next 10 |
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. (Nasdaq: PTCT) to acquire a portion of PTC’s royalty interest in risdiplam for a one-time payment of $650 million. Risdiplam, to be marketed by Ro...
Four IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow software provider Jamf (JAMF), environmental remediation company Montrose Environment (...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
VIRGINIA BEACH, Va. , June 30, 2020 /PRNewswire/ -- New Ventures Funds , a venture fund targeting investments in companies across healthcare and life sciences, is pleased to announce the IPO of its portfolio company, ADC Therapeutics (NYSE:ADCT). The company raised $267.6 million throu...
Point Roberts, WA and Delta, BC - June 26, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech and tech. This week's new biotech companies are i...
VIRGINIA BEACH, Va. , June 25, 2020 /PRNewswire/ -- New Ventures Funds , a venture fund targeting investments in companies across healthcare and life sciences, is pleased to announce the IPO of one of its portfolio companies, Royalty Pharma (NASDAQ:RPRX). The company raised $2.18 b...
Why is this a bad sign? I always like deals. I always say deals are a great sign of the health of the stock market. True, all true, but this is different. How many times has Michael Dell said that VMWare is central to the Dell/EMC ( DELL ) long-term strategy? How many times was the oppos...
Royalty Pharma ( RPRX ) is a very interesting and successful public offering, with shares having seen spectacular returns on their first few days of trading. The reason for the move higher is easily understood - an interesting business model which is very profitable and benefits from growing...
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma priced its upsized offering at the high end to raise $2.2 billion at...
A kind word means a lot Before I share my thoughts, I want to thank a kind reader who contacted me and said some encouraging things about my writing. I come to writing late in life, and never gave a thought to “Writer's Block,” it seemed like a precious, made-up thing for p...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...